Centrosomal amplification and aneuploidy induced by the antiretroviral drug AZT in hamster and human cells
- 1 June 2009
- journal article
- research article
- Published by Elsevier in Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis
- Vol. 665 (1-2) , 67-74
Abstract
No abstract availableKeywords
Funding Information
- National Cancer Institute
- National Institutes of Health
This publication has 27 references indexed in Scilit:
- Human inter-individual variability in metabolism and genotoxic response to zidovudineToxicology and Applied Pharmacology, 2008
- Cell death by mitotic catastrophe: a molecular definitionOncogene, 2004
- The Survivin/Aurora B Complex: Its Role in Coordinating Tension and AttachmentCell Cycle, 2003
- Centrosome amplification and the development of cancerOncogene, 2002
- Arrest of cell cycle progression during first interphase in murine zygotes microinjected with anti‐PCM‐1 antibodiesCell Motility, 2002
- Requirement of a Centrosomal Activity for Cell Cycle Progression Through G 1 into S PhaseScience, 2001
- Multiorgan Transplacental and Neonatal Carcinogenicity of 3′-Azido-3′-deoxythymidine in MiceToxicology and Applied Pharmacology, 1999
- Effect of L-carnitine on the zidovudine-induced destruction of human myotubes. Part I: L-carnitine prevents the myotoxicity of AZT in vitro.1994
- Enzymatic repair of oxidative DNA damage.1994
- The detergent-resistant cytoskeleton of tissue culture cells includes the nucleus and the microfilament bundlesExperimental Cell Research, 1977